AML-CD34+ showed higher CDK6-AS1 levels and mitochondria content than the more differentiated CD34− AML blasts, confirming that CDK6-AS1 overexpression positively correlated with mitochondrial biogenesis and mass in leukemia cells, especially in the CD34+ subpopulation. The gene discussed is CD34; the disease is acute myeloid leukemia.